TCL Archive FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one. September 16, 2005
TCL Archive Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget December 7, 2012
TCL Archive In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR May 6, 1994
TCL Archive Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin July 23, 2010
